Veracyte Q2 FY26 swings to GAAP net income of $25.5 million; revenue rises 15% to $150.3 million - VCYT News | RalliesVeracyte Q2 FY26 swings to GAAP net income of $25.5 million; revenue rises 15% to $150.3 million
V
VCYT• Q2 results
- Veracyte posted Q2 2026 GAAP net income of $25.5 million, swinging from a loss; diluted GAAP EPS was $0.31.
- Revenue rose 15% year over year to $150.3 million; testing revenue climbed 19% to $145.7 million.
- Adjusted EBITDA increased 23% to $44 million, lifting adjusted EBITDA margin to 29.2% from 27.5%.
- Total volume grew 13% to 50,967 tests, driven by Decipher testing revenue up 20% to $91.9 million.
Outlook and launches
- Raised 2026 revenue outlook to $590 million-$596 million; CEO Marc Stapley cited new launches Prosigna LDT, TrueMRD for MIBC.
